fbpx

How masculinity can affect men’s health behaviours with MS

How masculinity can affect men’s health behaviours with MSPublished: 17 August 2022 Male multiple sclerosis (MS) patients display different health-related behaviour depending on which masculine ideals they value, according to a new study. MS in men is less common – the condition affects women almost three times more than men,
Read More

How masculinity can affect men’s health behaviours with MS

How masculinity can affect men’s health behaviours with MSPublished: 17 August 2022 Male multiple sclerosis (MS) patients display different health-related behaviour depending on which masculine ideals they value, according to a new study. MS in men is less common – the condition affects women almost three times more than men,
Read More

Heart medication helps with remyelination in mouse study

Heart medication helps with remyelination in mouse studyPublished: 16 August 2022 Digoxin, a prescription-only drug for heart problems, has been found to promote myelin repair in a mouse model of multiple sclerosis (MS). Most drugs for MS modulate the immune system to try and control inflammation, but there is yet
Read More

Our HSCT journey and the story of AIMS Charity

Our HSCT journey and the story of AIMS Charity Alison Coates shares how HSCT for multiple sclerosis changed her husband's condition and paved the way for a new charity. Eleven and a half years ago, I was working in Malta assessing exams. On this particular night I’d gone to a
Read More

Smell test might predict DMT affectiveness

Smell test might help predict DMT effectivenessPublished 04 April 2022 A smell test could be used to tell whether treatments for multiple sclerosis (MS) are working or not, a new study suggests. Researchers in Austria teste whether measuring olfactory threshold (OT) could be a way to detect whether a person
Read More

Treatment that keeps half of people from relapsing for two years

Treatment that keeps half of people from relapsing for two years Published: 04 February 2022 More than half of people with multiple sclerosis (MS) who are treated with self-injected disease-modifying therapies (DMTs) had no evidence of disease activity after two years, a new study has found.  Turkish researchers wanted to
Read More

Drug due to be rejected by NICE for use on the NHS for MS

Drug due to be rejected by NICE for use on the NHS for MS Published: 21 December 2021 Famprya (fampridine) is set to be rejected by The National Institute for Health and Care Excellence (NICE) in England for use on the NHS for people with multiple sclerosis (MS). NICE will
Read More

New drug approved in Scotland for MS

New drug approved in Scotland for MSPublished: 13 July 2021 People living in Scotland can now be prescribed Kesimpta (ofatumumab),  The Scottish Medicines Consortium (SMC) has recommended. It will be available for those who have relapsing-remitting multiple sclerosis (MS) who are experiencing relapses or have disease activity visible with an
Read More
Image of covid-19 molecule

Possible new treatment for MS on the horizon

Possible new treatment for MS on the horizonPublished: 30 June 2021 A new less expensive, more convenient treatment for multiple sclerosis (MS) could be on the horizon.  Ublituximad, made by TG Therapeutics, has been shown to significantly reduce the annualised relapse rate in people with relapsing MS when compared with
Read More

Intranasal drug slows MS progression in mice study

Intranasal drug slows MS progression in mice studyPublished: 22 October 2020 A new study has found that an anti-inflammatory drug administered nasally may reduce the progression of multiple sclerosis (MS) in mice.  Researchers focused on molecules called inflammasomes which are responsible for the activation of the inflammatory response in the
Read More
  • 1
  • 2